Results 191 to 200 of about 7,704 (220)

Lumasiran in the Management of Patients with Primary Hyperoxaluria Type 1: From Bench to Bedside

International Journal of Nephrology and Renovascular Disease, 2022
Pietro Manuel Ferraro
exaly  

Ulcerations in Primary Hyperoxaluria

Advances in Skin & Wound Care, 2005
Jennifer T, Trent, Robert S, Kirsner
openaire   +2 more sources

Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium

Kidney International Reports, 2023
Cécile Acquaviva Bourdain, Justine Bacchetta, Pierre Cochat   +2 more
exaly  

Characterization of Stone Events in Patients With Type 3 Primary Hyperoxaluria

Journal of Urology, 2023
John C Lieske
exaly  

Oxalosis and primary hyperoxaluria

The Journal of Pathology and Bacteriology, 1959
E F, SCOWEN, A G, STANSFELD, R E, WATTS
openaire   +2 more sources

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

New England Journal of Medicine, 2021
Pierre Cochat, Hadas Shasha-Lavsky, Daniel G Fuster   +2 more
exaly  

Clinical features of genetically confirmed patients with primary hyperoxaluria identified by clinical indication versus familial screening

Kidney International, 2020
David J Sas Do, Xiao-Jing Tang, John C Lieske   +2 more
exaly  

A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3

Kidney International, 2021
Cristina Martin-Higueras, Dorrit E. Jacob, Justine Bacchetta   +2 more
exaly  

Clinical implications of mutation analysis in primary hyperoxaluria type 1

Kidney International, 2004
Ronald J A Wanders
exaly  

Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele

Kidney International, 2005
Dawn S Milliner
exaly